Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002) [Phase 3]

View source ↗

Summary

Phase 3 trial results for tapinarof in adults with plaque psoriasis have been completed and the results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapinarof (tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-10-13